{
  "zip": "08822",
  "sector": "Healthcare",
  "fullTimeEmployees": 4,
  "longBusinessSummary": "Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.",
  "city": "Flemington",
  "phone": "862-703-7170",
  "state": "NJ",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.arnothera.com",
  "maxAge": 1,
  "address1": "200 Route 31 North",
  "fax": "908-237-0071",
  "industry": "Biotechnology",
  "address2": "Suite 104",
  "previousClose": 0.00345,
  "regularMarketOpen": 0.00345,
  "twoHundredDayAverage": 0.002697029,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.00345,
  "navPrice": null,
  "averageDailyVolume10Day": 17557,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.00345,
  "fiftyDayAverage": 0.0030139394,
  "trailingAnnualDividendRate": null,
  "open": 0.00345,
  "averageVolume10days": 17557,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.803571,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.00345,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 30266,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 177659,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 30002,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.00345,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 30266,
  "fiftyTwoWeekHigh": 0.0048,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0013,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.00345,
  "exchange": "PNK",
  "shortName": "ARNO THERAPEUTICS INC",
  "longName": "Arno Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ARNI",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_33802737",
  "uuid": "632147eb-50e7-38c1-abf4-ba6f17003f5e",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": 0.176,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 49349700,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.119,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1451520000,
  "heldPercentInstitutions": 0.026800001,
  "netIncomeToCommon": -13695440,
  "trailingEps": -0.377,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1514678400,
  "mostRecentQuarter": 1475193600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 15026505,
  "enterpriseValue": -1948734,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1383091200,
  "lastSplitFactor": "1:8",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.00345,
  "logo_url": "https://logo.clearbit.com/arnothera.com"
}